Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595556 · ClinicalTrials.gov registry record · Phase 4
Zonisamide vs. Placebo in the Treatment of Alcohol Dependence
A Phase 4 study of Alcoholism and Alcohol Abuse, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00595556: Completed Phase 4 study of Alcoholism and Alcohol Abuse, sponsored by UConn Health.
NCT00595556 is a Phase 4 study of Alcoholism and Alcohol Abuse that has completed, run by UConn Health. The registered enrollment target is 40 participants, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595556, a Phase 4 study of Alcoholism and Alcohol Abuse, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study designed to examine the potential efficacy and tolerability of zonisamide compared to placebo for the treatment of alcohol dependence.
Primary Outcome
This outcome measure represents the change in number of heavy drinking days (i.e., 5 or more drinks per day for men, and 4 or more per day for women)per week, from baseline to the end of week twelve. This was analyzed using weekly measurements over the 12 week study period (thirteen time points, 12 measurements)with a repeated measures analysis (SPSS linear mixed models), by interaction with time (week).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG zonisamide
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
What the finished NCT00595556 record still lists
NCT00595556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00595556 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00595556 about?
NCT00595556 is a clinical study titled "Zonisamide vs. Placebo in the Treatment of Alcohol Dependence". This is a pilot study designed to examine the potential efficacy and tolerability of zonisamide compared to placebo for the treatment of alcohol dependence.
What is the current status of trial NCT00595556?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-07. Estimated completion is 2009-05.
What conditions does trial NCT00595556 study?
This clinical trial studies the following conditions: Alcoholism, Alcohol Abuse, Alcohol Dependence.
What interventions are being tested in trial NCT00595556?
The interventions under investigation include: Placebo (DRUG), zonisamide (DRUG).
Who is sponsoring clinical trial NCT00595556?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00595556 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00595556's enrollment target sits among peer trials
40 54th of 65 higher than 9 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Naltrexone in AUD Reward Drinkers
RECRUITING · Phase 4
-
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
COMPLETED · Phase 4
-
Naltrexone, Craving, and Drinking
COMPLETED · Phase 4
-
Sertraline Pharmacotherapy for Alcoholism Subtypes
COMPLETED · Phase 4
-
Naltrexone for Heavy Drinking in Young Adults
COMPLETED · Phase 4
-
Managing Alcoholism in People Who Do Not Respond to Naltrexone
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia